Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vaxcyte, Inc. is a vaccine innovation company developing broad-spectrum conjugate and protein vaccines targeting bacterial infectious diseases. Utilizing advanced synthetic chemistry and cell-free protein synthesis platforms, it focuses on pneumococcal, Group A Streptococcus, periodontitis, and shigellosis vaccines for adult and pediatric markets. Its core value lies in creating highly immunogenic, scalable, and next-generation vaccines to address unmet medical needs and improve global health.
This description was generated via AI from an annual report. Updated about 1 year ago.